Safety of Single and Repeat Treatments of DaxibotulinumtoxinA for Injection for Treatment of Moderate to Severe Glabellar Lines
NCT03004248
·
clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
2691
Enrollment
INDUSTRY
Sponsor class
Conditions
Glabellar Frown Lines
Interventions
BIOLOGICAL:
Botulinum Toxins, Type A
Sponsor
Revance Therapeutics, Inc.